A recent report indicates that GSK3β-mediated inhibition of glycogen synthase down-regulatesPD-1 expression levels on CD8+ T cells in B16F10, murine melanoma cells (136).Several reports also suggest the role of AMPK as an immune checkpoint inhibitor. This evidence concerns the gene PRKAA2 and melanoma.